Opinion
Video
Author(s):
Jason Hafron, MD, CMO, provides an overview of the QUILT trial investigating N-803 in patients with BCG-unresponsive high-grade non–muscle invasive bladder cancer.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.